Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
CStone Pharmaceuticals (2616 HK)
Watchlist
92
Analysis
Health Care
•
Hong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
30 Dec 2024 19:05
List Of Directors And Their Role And Function
Attachment
Exchange Announcement •
30 Dec 2024 19:00
Appointment Of Independent Non-Executive Director
Attachment
Exchange Announcement •
23 Dec 2024 08:00
Voluntary Announcement - Cstone Announces Submission Of Clinical Trial Application In Australia For Cs2009, An Innovative Pd-1/Vegf/Ctla-4 Trispecific Antibody
Attachment
Exchange Announcement •
19 Dec 2024 08:02
Voluntary Announcement - Cstone Announces First Patient Enrolled In The Global Multicenter Phase Ib Clinical Trial Of Cs5001 (Ror1 Adc)
Attachment
Exchange Announcement •
09 Dec 2024 08:00
Voluntary Announcement - Cstone Presents Latest Clinical Data On Cs5001 For Advanced Lymphoma At The 66th Ash Annual Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x